Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma (Q34107623)
Jump to navigation
Jump to search
scientific article
- Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma |
scientific article |
|
Statements
1 reference
Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma (English)
1 reference
Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma (English)
0 references
Stanislaw M Mikulski
1 reference
John J Costanzi
1 reference
Nicholas J Vogelzang
1 reference
Spence McCachren
1 reference
Robert N Taub
1 reference
Hoo Chun
1 reference
Abraham Mittelman
1 reference
Timothy Panella
1 reference
Carmelo Puccio
1 reference
Robert Fine
1 reference
Kuslima Shogen
1 reference
1 January 2002
1 reference
January 2002
0 references
1 reference
Identifiers
1 reference